New York, NY -- (SBWIRE) -- 10/24/2013 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: American Graphite Technologies Inc(OTCBB:AGIN), FUSE SCIENCE, INC(OTCMKTS:DROP), CAN-FITE BIOPHARMA(OTCMKTS:CANFY) , International Stem Cell Corp(OTCMKTS:ISCO)
American Graphite Technologies Inc(OTCBB:AGIN), during the previous trading session, showed a negative movement of -9.30%.Year to date performance of the stock remained negative with the decline of -75.62%. The stock traded with volume of1.09million shares, while its average trading volume remained 397,456.00 shares. Its closing price was $0.195 while it started its day-trade at $0.23. Its 52-week price range was $0.12 - $2.00. American Graphite Technologies Inc., an exploration stage company, focuses on the acquisition, exploration, and development of graphite related mineral properties primarily in the United States. The company was formerly known as Green & Quality Home Life, Inc. and changed its name to American Graphite Technologies Inc. in July 2012. American Graphite Technologies Inc. was founded in 2010 and is based in Las Vegas, Nevada.
Has AGIN Found The Bottom and Ready To Move Up? Find Out Here
FUSE SCIENCE, INC(OTCMKTS:DROP) remained among the day losers and traded with volume of 2.20 million shares in the last session, as compared to average volume of 1.40 million shares.Previous 5 days graph demonstrated an optimistic move of -24.62%. Its quarterly performance remained in the red with the percentage of -45.25, while its year to date performance showed that the stock plunged overall -72.47%. Fuse Science, Inc., a consumer products company, develops alternative delivery systems with applications in the sports nutrition and medical fields.
Has DROP Found The Bottom And Ready To Gain Momentum? Find Out Here
CAN-FITE BIOPHARMA(OTCMKTS:CANFY) started its trading session with the price of $6.30 and closed at $6.33 by losing -8.53%. It traded with total volume of 137,877.00 shares, while the average trading volume remained 11,341.00 shares. The 52 week range of the stock remained 3.30 - $7.00, while its day lowest price was $5.94 and it hit its day highest price at $6.40. The company’s total market capitalization is $49.38 million along with 285,461 shares outstanding. Can-Fite BioPharma, Ltd., a biotechnology company, develops drugs for the treatment of cancer and autoimmune inflammatory diseases.
Why Should Investors Buy CANFY After the Recent Fall? Just Go Here and Find Out
International Stem Cell Corp(OTCMKTS:ISCO) stock made opening at $0.17 and, as day trade closed, its price was $ 0.158 after losing -12.22% . Total traded volume of the stock was 1.23 million shares, while company’s average volume remained 841,024.00 shares. The intraday price range was $0.15 - $0.17, while its 52 week range was $0.13- $0.41. International Stem Cell Corporation, a developmental stage biotechnology company, engages in the development and commercialization of therapeutic, biomedical, and cosmeceutical products in the United States and internationally. Its products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cells.
Will ISCO Get Buyers Even After The Recent Rally? Find Out Here
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)